Directory

>

Kevin Lumb

avatar

Kevin Lumb

Vice President, Discovery Sciences | Monte Rosa Therapeutics

Upper Providence Township, Pennsylvania, United States

View contact details (it's free)

Kevin Lumb

Summary

Kevin Lumb is a seasoned leader in drug discovery, specializing in pharmacology and structural biology. With a proven track record of building high-performing teams, he has effectively managed both internal and external resources to drive innovative drug development. His expertise spans from target validation to preclinical candidate discovery, showcasing his ability to navigate complex processes and clarify executable strategies. Kevin has authored 54 publications and holds 9 patents, reflecting his deep commitment to advancing scientific knowledge. His leadership style emphasizes talent development and creating self-managing teams, fostering an environment of collaboration and innovation. He has successfully led teams in various prestigious organizations, including Merck and Janssen, demonstrating his adaptability across different corporate cultures. Kevin's strategic vision in capital planning and execution has also garnered him recognition in investor relations. Currently serving as Vice President of Discovery Sciences at Monte Rosa Therapeutics, he continues to make significant contributions to the life sciences industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Startup Experience

Kevin Lumb

Work Experience

company logo

Vice President, Discovery Sciences at

Monte Rosa Therapeutics

January 2023 - Present

company logo

Vice President, Biology at

Avilar Therapeutics, Inc.

January 2021 - January 2023

company logo

Global Head, Lead Discovery & Profiling, Discovery Sciences at

The Janssen Pharmaceutical Companies of Johnson & Johnson

January 2016 - January 2020

company logo

Scientific Director, Emerging Science & Innovation, Discovery Sciences at

The Janssen Pharmaceutical Companies of Johnson & Johnson

January 2014 - January 2016

company logo

Department Head, Protein Science at

Merck

January 2012 - January 2014

company logo

Department Head, Biochemical Screening/Global Structural Biology at

Merck

January 2009 - January 2012

company logo

Department Head, Global Structural Biology at

Merck

January 2007 - January 2009

company logo

Principal Scientist, Research Technologies at

Bayer AG

January 2004 - January 2007

company logo

Senior Scientist, Research Technologies at

Bayer Pharmaceuticals

January 2002 - January 2004

Logos provided by Logo.dev

Kevin Lumb

Education

University of Oxford, Doctor Of Philosophy (D.Phil.)

Whitehead Institute at MIT, Postdoctoral Research

University College London, Bachelor Of Science With Honours (B.Sc.)

Frequently Asked Questions about Kevin Lumb

What is Kevin Lumb email address?

Kevin Lumb's primary email address is *****@monterosatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Kevin Lumb work for?

Kevin Lumb is a Vice President, Discovery Sciences at Monte Rosa Therapeutics, a company specializing in Commercial physical research.

Where Kevin Lumb graduated from?

Kevin Lumb holds a degree in Biophysics And Structural Biology (Advisor: Sir Christopher M. Dobson Frs) from University of Oxford.

How can I directly contact Kevin Lumb?

To contact Kevin Lumb directly, you can use the email address *****@monterosatx.com. Complete contact information is available upon registration with Muraena.

Who is Kevin Lumb?

Kevin Lumb is a seasoned leader in drug discovery, specializing in pharmacology and structural biology. With a proven track record of building high-performing teams, he has effectively managed both internal and external resources to drive innovative drug development. His expertise spans from target validation to preclinical candidate discovery, showcasing his ability to navigate complex processes and clarify executable strategies. Kevin has authored 54 publications and holds 9 patents, reflecting his deep commitment to advancing scientific knowledge. His leadership style emphasizes talent development and creating self-managing teams, fostering an environment of collaboration and innovation. He has successfully led teams in various prestigious organizations, including Merck and Janssen, demonstrating his adaptability across different corporate cultures. Kevin's strategic vision in capital planning and execution has also garnered him recognition in investor relations. Currently serving as Vice President of Discovery Sciences at Monte Rosa Therapeutics, he continues to make significant contributions to the life sciences industry.

Kevin`s contact details

mail

*****@monterosatx.com

**********@avilar-tx.com

Colleagues

avatar
Filip Janku

Chief Medical Officer

avatar
Ed Dunn

VP - Corporate Controller, Principal Accounting Officer

avatar
Karin Von Hodenberg

Vice President of Quality

avatar
Bernhard Fasching

Vice President, Chemistry at Monte Rosa Therapeutics

avatar
Debora Bonenfant

Vice-President, Head of Proteomics

avatar
Ralph Tiedt

VP Oncology

avatar
Chris King

VP of Nonclinical Development & Clinical Pharmacology

avatar
John Castle

Chief Information Officer

avatar
Jennifer Champoux

Chief Operating Officer

avatar
Alison Paterson

Vice President

View Contact details (it's free)
Request Profile Removal